FDA approves shock wave device for treatment of diabetic foot ulcers

January 1, 2018February 25, 2020 Wound Care Advisor

On December 28, 2017, the FDA gave approval for the Dermapace System, a shock wave device intended to be used in the treatment of chronic, full-thickness diabetic foot ulcers. The device uses pulses of energy, similar to sound waves, to mechanically stimulate the wound. Read more.

Related posts

• 

  Why do older people heal more slowly?

  By Matthew Steinhauser, University of Pittsburgh I recently visited...

• 

  A young Black scientist discovered a pivotal leprosy treatment in the 1920s − but an older colleague took the credit

  By Mark M. Lambert, Des Moines University Hansen’s disease,...

• 

  Leprosy cases are rising in the US – what is the ancient disease and why is it spreading now?

  By Robert A. Schwartz, Rutgers University The word “leprosy”...

• 

  Flesh-eating bacteria infections are on the rise in the US

  By Bill Sullivan, Indiana University Flesh-eating bacteria sounds like...

• 

  Rare ‘Flesh-Eating’ Bacterium Spreads North as Oceans Warm

  By Christopher O’Donnell, Tampa Bay Times Debbie King barely...

• 

  Silk wound dressing helps eliminate scar tissue formation

  Researchers from Huazhong University of Science and Technology, China...